Brief: ANI Pharmaceuticals Announces FDA Approval And Launch Of Naproxen Delayed-Release Tablets, USP
02/07/2024 12:58
July 2 (Reuters) - ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS - U.S. ANNUAL SALES FOR NAPROXEN
TABLETS
ABOUT $36.7 MILLION, BASED ON APRIL MAT IQVIA DATA
* ANI PHARMACEUTICALS ANNOUNCES THE FDA APPROVAL AND LAUNCH
OF
NAPROXEN DELAYED-RELEASE TABLETS, USP
Source text for Eikon: ID:
Further company coverage: ANIP.O
Recent news on ANI Pharmaceuticals
See all newsBrief: Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary